Moxifloxacin versus ethambutol in initial tuberculosis treatment

Lancet. 2009 Jun 27;373(9682):2198; author reply 2198-9. doi: 10.1016/S0140-6736(09)61189-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Aza Compounds / therapeutic use*
  • Drug Administration Schedule
  • Ethambutol / therapeutic use*
  • Fluoroquinolones
  • Humans
  • Medication Adherence
  • Moxifloxacin
  • Patient Selection
  • Practice Guidelines as Topic
  • Quinolines / therapeutic use*
  • Sputum / microbiology
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / microbiology

Substances

  • Antitubercular Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Ethambutol
  • Moxifloxacin